Search
for
Sort by
Research 631–660 of 1000+
- Finasteride induced depression: a prospective study
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Green Tea as a Supportive Therapy for PCOS: Evaluating Its Impact on Symptom Relief
- Association of Cyp11a Gene with Polycystic Ovarian Syndrome Patients in Lahore, Pakistan
- Evaluation and treatment of male and female pattern hair loss
- Pregnancy and the Skin
- Deletion of Deoxyribonucleic Acid Binding Domain of the Vitamin D Receptor Abrogates Genomic and Nongenomic Functions of Vitamin D
- GABRA2 Alleles Moderate the Subjective Effects of Alcohol, Which are Attenuated by Finasteride
- A Simple Screening Approach for Assessing Community Prevalence and Phenotype of Polycystic Ovary Syndrome in a Semiurban Population in Sri Lanka
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Physiology of the Hypothalamic Pituitary Gonadal Axis in the Male
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Prevalence of hepatic steatosis in women with polycystic ovary syndrome
- Update on the dermatologic use of systemic glucocorticosteroids
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Physiological Skin Changes During Pregnancy
- Enhanced remyelination during late pregnancy: involvement of the GABAergic system
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)
- Dapsone Therapy for Pustular Psoriasis: Case Series and Review of the Literature
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Skin disease in pregnancy
- Hormone therapy in acne
- Emerging Therapies for Acne Vulgaris
- Acne severity and the Global Acne Grading System in polycystic ovary syndrome